# Stratification of Presymptomatic Amyotrophic Lateral Sclerosis: the Development of Novel Imaging Biomarkers

> **NCT05358431** · NA · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 120 (estimated)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **OTHER:** Neuroimaging and electrophysiology

## Key facts

- **NCT ID:** NCT05358431
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-21
- **Primary completion:** 2026-02-21
- **Final completion:** 2026-02-21
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2024-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05358431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05358431, "Stratification of Presymptomatic Amyotrophic Lateral Sclerosis: the Development of Novel Imaging Biomarkers". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05358431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*